1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > 2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500.


“2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

 

Rationale


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

  

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.


Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.


Opportunities and Strategic Recommendations


- Emerging opportunities for new instrumentation,

  reagents kits, IT and other products with significant market

  appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,

Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,

Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Market Segmentation Analysis


- Sales and market shares of major suppliers

  by individual test.


- Volume and sales forecasts for over 100 infectious disease

   assays by individual test and market segment:


Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories

- Blood Banks

- Public Health Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers


- Test volume estimates by method (molecular, serology/immunodiagnostics,

   culture/microscopy).


- Review of the market dynamics, trends,

  structure, size, growth and major suppliers.


Current and Emerging Products


- In-depth examination of over 100 major diseases,

  including their etiology, current diagnostic tests,

  vaccines, drugs and market needs.


- Review of major analyzers used for infectious disease

  testing, including their operating

  characteristics, features and selling prices.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,

  immunoassay, and other technologies and their potential

  applications for infectious disease testing.


- Global listings of companies developing or

  marketing infectious disease diagnostic products

  by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and

  emerging market entrants, including their sales, product

  portfolios, marketing tactics, collaborative

  arrangements and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - Affymetrix

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomerieux

   - Bio-Rad

   - Cepheid      

   - Diamedix           

   - Diasorin

   - Eiken Chemical

   - Elitech Group

   - Enzo Biochem

   - Fujirebio

   - Grifols

   - Hologic/Gen-Probe

   - ID Biomedical/GSK

   - Kreatech/Leica

   - Lonza

   - Ortho-Clinical Diagnostics

   - Qiagen

   - Roche

   - Scienion

   - Sequenom

   - SeraCare

   - Siemens

   - Takara Bio

   - ThermoFisher

   - Wallac/PE

   - Wako


Contains 1,060 pages and 192 tables

“2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Table Of Contents

2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

Table of Contents
I. Introduction
II. Major Product Development Opportunities
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
Table of Contents (Continued)
7. Bilirubin, Total
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cardio CRP
12. Cholesterol
13. Cholinesterase
14. CRP
15. Creatinine
16. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
17. Ferritin
18. Fructosamine
19. Gamma-Glutamyl Transpeptidase (GGT)
20. Glucose
21. High Density Lipoprotein (HDL)
22. Homocysteine
23. Iron
24. Lactate Dehydrogenase (LDH)
25. Magnesium
26. Phosphorus
27. Protein
28. Triglycerides
29. Uric Acid
30. Troponin
B. Therapeutic Drug Monitoring (TDM)
1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. NAPA/Procainamide
Table of Contents (Continued)
12. Phenytoin
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Theophylline
17. Topirimate
18. Valproic Acid
C. Endocrine Function Tests
1. Cortisol
2. Estradiol
3. Follicle-Stimulating Hormone (FSH)
4. Gastrin
5. Growth Hormone/IGF-1
6. Human Chorionic Gonadotropin (HCG)
7. LH
8. Progesterone
9. PTH/IO PTH
10. Prolactin
11. T3
12. T3 Free
13. T3 Uptake
14. T4 (Thyroxine)
15. T4 Free
16. TBG
17. Testosterone
18. Thyroglobulin Ab
19. TPO Ab
20. TSH
D. Tumor Markers And Special Chemistry Tests
1. AFP
2. CA 15-3
3. CA 19-9
4. CA 27-29
5. Carcinoembrionic Antigen (CEA)
6. Folate/Folic Acid
7. HCG
8. 25-Hydroxy Vitamin D2 and D3
Table of Contents (Continued)
9. Occult Blood
10. Prostate-Specific Antigen (PSA)
11. Thyroglobulin
12. Vitamin B-12
E. Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Free Light Chains
3. Immunofixation
4. Immunoglobulins (IgA, IgE, IgG, IgM)
5. Haptoglobin
6. Prealbumin
7. Protein Electrophoresis
F. Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
G. Instrumentation Review: Operating characteristics
and features of high-, medium-, and low-volume/POC analyzers
H. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
Table of Contents (Continued)
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
VII. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
E. Market Size, Growth and Major Suppliers'
Instrument and Reagent Sales and Market Shares
VIII. Competitive Strategies
- Abbott Laboratories
- AdnaGen
- Agilent Technologies
Table of Contents (Continued)
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE


List of Tables
Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests


Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin/Dilantin Tests

Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Acid Tests
Major Companies Developing or Marketing
FSH Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
LH Tests
Major Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase Tests

Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests
Major Companies Developing or Marketing
CRP Tests
Major Companies Developing or Marketing
Drugs of Abuse Tests
Major Companies Developing or Marketing
Biosensors for Immunological Testing
Executive Summary Table: U.S.A., Clinical
Chemistry and Immunoassay Test Volume
and Diagnostics Sales Forecast By Test Category
U.S.A., Laboratories Performing Chemistry
and Immunoassay Testing By Market Segment
U.S.A., Hospital Laboratories Performing
Chemistry and Immunoassay Tests By Bed Size

U.S.A., Commercial/Private Laboratories
Performing Chemistry and Immunoassay Tests
By Annual Test Volume
U.S.A., Total Chemistry and Immunoassay
Specimen Volume Forecast
U.S.A., All Market Segments, Specimen Volume
Forecast By Test Category
U.S.A., Total Clinical Chemistry and Immunoassay
Test Volume Forecast By Test Category
U.S.A., Routine Chemistry Test Volume
Forecast By Market Segment
U.S.A., TDM Test Volume Forecast
By Market Segment

U.S.A., Endocrine Function Test Volume
Forecast By Market Segment
U.S.A., Drugs of Abuse Test Volume
Forecast By Market Segment
U.S.A., Tumor Markers and Special Chemistry
Test Volume Forecast By Market Segment
U.S.A., Immunoprotein Test Volume
Forecast By Market Segment
U.S.A., All Market Segments, Profiles,
Panels and Individual Tests Forecast
U.S.A., Hospital Laboratories, Profiles,
Panels and Individual Tests Forecast
U.S.A., Commercial/Private Laboratories,
Profiles, Panels and Individual Tests Forecast

U.S.A., Physician Offices/Group Practices,
Profiles, Panels and Individual Tests Forecast

U.S.A., All Market Segments, Routine
Chemistry Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories, Routine
Chemistry Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Routine Chemistry Test Volume Forecast
by Assay

U.S.A., All Market Segments, TDM
Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, TDM
Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices,
TDM Test Volume Forecast by Assay
U.S.A., All Market Segments, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Test Volume Forecast
by Assay
U.S.A., All Market Segments, Drugs
of Abuse Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Drugs
of Abuse Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Test Volume Forecast
by Assay

U.S.A., All Market Segments, Tumor Markers
and Special Chemistry Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories, Tumor Markers
and Special Chemistry Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Tumor Markers and Special Chemistry Test
Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Tumor Markers and Special Chemistry Test
Volume Forecast by Assay
U.S.A., All Market Segments,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Total Clinical Chemistry and Immunoassay
Reagent Market Forecast By Test Category
U.S.A., Clinical Chemistry and Immunoassay
Calibrator and Control Market Forecast
By Test Category
U.S.A., Routine Chemistry Reagent Market
Forecast By Market Segment

U.S.A., TDM Reagent Market Forecast
By Market Segment

U.S.A., Drugs of Abuse Reagent Market
Forecast By Market Segment
U.S.A., Tumor Markers and Special Chemistry
Reagent Market Forecast By Market Segment
U.S.A., Endocrine Function Reagent Market
Forecast By Market Segment
U.S.A., All Market Segments, Routine
Chemistry Reagent Market Forecast
by Assay
U.S.A., Hospital Laboratories, Routine
Chemistry Reagent Market Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Reagent Market Forecast
by Assay

U.S.A., Physician Offices/Group Practices,
Routine Chemistry Reagent Market Forecast
by Assay
U.S.A., All Market Segments, TDM
Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, TDM
Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
U.S.A., Physician Office/Group Practices,
TDM Reagent Market Forecast by Assay

U.S.A., All Market Segments, Drugs of
Abuse Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of
Abuse Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., All Market Segments, Endocrine
Function Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Reagent Market Forecast
by Assay
U.S.A., All Market Segments, Tumor Markers
and Special Chemistry Reagent Market Forecast
by Assay

U.S.A., Hospital Laboratories, Tumor Markers
and Special Chemistry Reagent Market Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Tumor Markers and Special Chemistry Reagent
Market Forecast by Assay

U.S.A., Physician Offices/Group Practices,
Tumor Markers and Special Chemistry Reagent
Market Forecast by Assay
U.S.A., All Market Segments,
Immunoprotein Reagent Market Forecast
U.S.A., Hospital Laboratories,Immunoprotein
Reagent Market Forecast Immunoprotein
U.S.A., Commercial/Private Laboratories,
Immunoprotein Reagent Market Forecast
U.S.A., Physician Offices/Group Practices,
Immunoprotein Reagent Market Forecast
by Assay
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine
And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments
Profiles, Panels and Individual Tests

U.S.A., Hospital Emergency Departments
Routine and Special Chemistry Reagent
Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Reagent
Market Forecast by Test
U.S.A., Hospital ICUs/CCUs Routine
And Special Chemistry Test Volume Forecast

U.S.A., Hospital ICUs/CCUs Routine
And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine
And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry
Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers Routine
And Special Chemistry Test Volume Forecast

U.S.A., Surgery Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes
Estimated Number of Facilities,
Beds and Occupancy Rate
U.S.A., Nursing Homes Routine
And Special Chemistry Test Volume Forecast

U.S.A., Nursing Homes Routine
And Special Chemistry Reagent Market Forecast by Test


U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles,
Panels and Individual Tests
U.S.A., Birth Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry
Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Clinical Chemistry
Analyzers, Estimated Instrument Sales
and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Diagnostics Products, Estimated Sales
and Market Shares
U.S.A., Major Suppliers of Immunoassay
Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay
Analyzers, Estimated Instrument Sales
and Market Shares
U.S.A., Major Suppliers of Immunoassay
Diagnostics Products, Estimated Sales
And Market Shares
U.S.A., Clinical Chemistry and Immunoassay
Instrument Market Forecast By Analyzer Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.